0001365618-16-000008.txt : 20160415
0001365618-16-000008.hdr.sgml : 20160415
20160415211407
ACCESSION NUMBER: 0001365618-16-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160414
FILED AS OF DATE: 20160415
DATE AS OF CHANGE: 20160415
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anacor Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001411158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251854385
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
BUSINESS PHONE: 650-543-7500
MAIL ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
FORMER COMPANY:
FORMER CONFORMED NAME: Anacor Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hove Anders D
CENTRAL INDEX KEY: 0001365618
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34973
FILM NUMBER: 161575621
MAIL ADDRESS:
STREET 1: 30 ROCKEFELLER PLAZA, SUITE 5508
CITY: NEW YORK
STATE: NY
ZIP: 10112
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2016-04-14
0001411158
Anacor Pharmaceuticals, Inc.
ANAC
0001365618
Hove Anders D
C/O VENROCK
3340 HILLVIEW AVE.
PALO ALTO
CA
94304
1
0
0
0
Common Stock
2016-04-14
4
C
0
257647
31.05
A
353881
I
By Funds and LLC's
Common Stock
33886
D
2.00% Convertible Senior Notes due 2021
31.05
2016-04-14
4
C
0
8000000.00
0
D
2021-10-15
Common Stock
257647
0
I
By Funds and LLC's
The conversions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Venrock Healthcare Capital Partners, L.P. ("VHCP"), VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest"), Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), VHCP Co-Investment Holdings II, LLC ("VHCP Co-Invest II"), Venrock Associates IV, L.P. ("VA4"), Venrock Partners, L.P. ("VP") and Venrock Entreprenerus Fund IV, L.P. ("VEF4") on March 16, 2016.
The shares are held as follows: 44,464 shares held by VA4, 9,068 shares held by VP, 1,092 shares held by VEF4, 100,521 shares held by VHCP, 18,383 shares held by VHCP Co-Invest, 151,658 shares held by VHCP II, and 28,695 shares held by VHCP Co-Invest II.
Venrock Management IV, LLC ("VM4"), Venrock Partners Management, LLC ("VPM") and VEF Management IV, LLC ("VEFM4") are the sole general partners of VA4, VP and VEF4, respectively, and may be deemed to beneficially own these shares. VHCP Management, LLC ("VHCP Management") is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. VHCP Management II, LLC ("VHCP Management II") is the general partner of VHCP II and the manager of VHCP Co-Invest II and may be deemed to beneficially own these shares. Anders Hove is a member of VM4, VPM and VEFM4 and a managing member of VHCP Management and VHCP Management II. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA4, VP, VEF4, VHCP, VHCP Co-Invest, VHCP II, VHCP Co-Invest II, VM4, VPM, VEFM4, VHCP Management and VHCP Management II except to the extent of his indirect pecuniary interest therein.
The reporting person is a member of VR Management, LLC (the "Management Company"). Under an agreement between the reporting person and the Management Company, the reporting person is deemed to hold an aggregate of 794 of the reported securities for the sole benefit of the Management Company (the "Management Company Shares"). The Management Company may be deemed the indirect beneficial owner of the Management Company Shares, and the reporting person may be deemed the indirect beneficial owner of the Management Company Shares through his interest in the Management Company. The reporting person disclaims beneficial ownership of the Management Company Shares except to the extent of his indirect pecuniary interest therein.
The 2.00% Convertible Senior Notes due 2021 were convertible into common stock at a conversion price equal to $31.05 (32.2061 shares of common stock for each $1,000 worth of principal) on the date of conversion.
/s/ Anders D. Hove
2016-04-15